Cost-Effectiveness of Combination Disease-Modifying Antirheumatics vs. Tumour Necrosis Factor Inhibitors in Active Rheumatoid Arthritis: TACIT Trial

Arthritis Care and Research - United States
doi 10.1002/acr.23830
Full Text
Abstract

Available in full text

Categories
Rheumatology
Date
Authors
Publisher

Wiley


Related search